Tang Capital Partners LP

10% OwnerRain Oncology Inc. (RAIN) · full profile →Form 4 · filed Dec 18, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$209K
Net Open-Market Flow
-$209K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2023Sell(S)40K$1.21$49K3.9M
Dec 15, 2023Sell(S)109K$1.20$131K3.9M
Dec 14, 2023Sell(S)24K$1.21$30K4.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-23-016655) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about RAIN insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001415889-23-016655"
Ask your agent
Use Arkolith to summarize insider buying and selling at Rain Oncology Inc.
over the last 90 days and cite the filings.